Leucemia linfocítica crónica

Solicite una Consulta

Survival rates

Survival rates are different for each person with chronic lymphocytic leukemia. Healthcare professionals use something called a prognostic score to determine the chances of surviving certain types of cancers. Prognostic scores for chronic lymphocytic leukemia range from 0 to 10. The higher your score, the lower your chance of survival. Your score is determined by:

  • Your age.
  • Whether certain gene changes are present in your cancer.
  • How much of a specific protein is in your blood.
  • The stage of your cancer.

For example, chronic lymphocytic leukemia has a five-year survival rate of about 90% at a score of 0 to 1. The 10-year survival rate for a score of 0 to 1 is about 86%. As the score gets higher, the survival rate gets lower. For chronic lymphocytic leukemia with a score of 7 to 10, the chance of surviving at least five years is about 23%. The 10-year survival rate for a score of 7 to 10 is 0%.

Keep in mind that survival statistics take five or 10 years to collect. The most recent survival rates include people who had treatment for chronic lymphocytic leukemia more than five years ago. These people may not have had access to the latest treatments. Over the last few decades, chronic lymphocytic leukemia death rates have been falling and survival rates have been increasing.

Solicite una consulta
Diagnóstico y tratamiento
April 30, 2025

Living with leucemia linfocítica crónica?

Connect with others like you for support and answers to your questions in the Blood Cancers & Disorders support group on Mayo Clinic Connect, a patient community.

Blood Cancers & Disorders Discussions

roberthall0452
Anyone else have Mantle Cell Lymphoma?

99 Replies Thu, Oct 23, 2025

dax1million
Myelofibrosis: Anyone have experience with Vonjo (pacritinib)?

31 Replies Thu, Oct 23, 2025

Frazer 1
Want to talk about Multiple Myeloma: Anyone else?

419 Replies Thu, Oct 23, 2025

See more discussions
  1. Niederhuber JE, et al., eds. Chronic lymphocytic leukemia. In: Abeloff's Clinical Oncology. 6th ed. Elsevier; 2020. https://www.clinicalkey.com. Accessed April 13, 2021.
  2. Kaushansky K, et al., eds. Chronic lymphocytic leukemia. In: Williams Hematology. 10th ed. McGraw Hill; 2021. https://accessmedicine.mhmedical.com. Accessed April 13, 2021.
  3. AskMayoExpert. Chronic lymphocytic leukemia (CLL) (adult). Mayo Clinic; 2019.
  4. Chronic lymphocytic leukemia/small lymphocytic leukemia. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1478. Accessed April 13, 2021.
  5. Chronic lymphocytic leukemia treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/types/leukemia/patient/cll-treatment-pdq. Accessed April 13, 2021.
  6. Cancer-related fatigue. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1424. Accessed April 13, 2021.
  7. Warner KJ. Allscripts EPSi. Mayo Clinic. Feb. 8, 2021.
  8. Shanafelt TD, et al. Hematologist/oncologist disease-specific expertise and survival: Lessons from chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL). Cancer. 2012; doi:10.1002/cncr.26474.
  9. Ding W, et al. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood. 2017; doi:10.1182/blood-2017-02-765685.
  10. Archibald WJ, et al. Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: Risk prediction, management and clinical outcomes. Annals of Hematology. 2021; doi:10.1007/s00277-020-04094-3.
  11. Lymphoma SPOREs. National Cancer Institute. https://trp.cancer.gov/spores/lymphoma.htm. Accessed April 23, 2021.
  12. Sites. Chronic lymphocytic leukemia Research Consortium (CRC). https://cll.ucsd.edu/research-sites. Accessed April 23, 2021.
  13. Slager SL, et al. Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families. Blood. 2021; doi:10.1182/blood.2020006322.

Leucemia linfocítica crónica